SCHEMBL5991973

SCHEMBL5991973

O=CNCc1ccc(-c2ccccn2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.55
ADH1C P00326 1/20 0.55
ADH1A P07327 1/20 0.55
ADH7 P40394 1/20 0.55
HCAR2 Q8TDS4 1/20 0.43
CYP2D6 P10635 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP19A1 P11511 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
CCNE1 P24864 3/20 0.43
CDK2 P24941 3/20 0.43
CDK5 Q00535 2/20 0.43
CYP2A6 P11509 1/20 0.42
CXCR4 P61073 1/20 0.42
HIF1A Q16665 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14957567 0.82 CYP1A2 (0.47) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL16781356 0.81 CXCR4 (0.50) HCAR2CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL933590 0.80 CYP1A2 (0.47) HCAR2CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL18179877 0.79 MAOA (0.52) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL3517425 0.79 CA12 (0.48) HCAR2CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL2237883 0.78 ADRB2 (0.51) HCAR2CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL3722162 0.78 IDO1 (0.50) HCAR2CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL27607143 0.77 CA12 (0.47) HCAR2CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL1691160 0.77 ADH1B (0.76) ADH1BADH1CADH1AADH7CYP2D6
SCHEMBL5451697 0.77 ADH1B (0.76) ADH1BADH1CADH1AADH7CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060287378-A1 Novel pyrroles and imidazoles WARNER-LAMBERT COMPANY LLC 2006-12-21 US disclosed
US-20050239857-A1 Novel imidazoles BOLTON GARY L 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287378-A1 Novel pyrroles and imidazoles PPIP5K2, PPIE, PPOX ADH1B 883/4885ADH1C 336/4885ADH1A 293/4885
US-20050239857-A1 Novel imidazoles HMGCR, HMGB2, HMGB3 ADH1B 68/4885ADH1C 426/4885ADH1A 304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.